PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Centre for Research and Knowledge Transfer in Biotechnology, University of Zagreb, Zagreb, Croatia.\', \'Center of Excellence for Virus Immunology and Vaccines (CERVirVac), Zagreb, Croatia.\', \'Croatian Institute of Transfusion Medicine, Zagreb, Croatia.\', \'Research Department, University Hospital for Infectious Diseases \'Dr. Fran Mihaljević\', Zagreb, Croatia.\', \'Clinics for Pulmonary Diseases, University Hospital Centre Zagreb, Zagreb, Croatia.\', \'Department of Hematology, University Hospital Dubrava, Zagreb, Croatia.\', \'Department for Transfusion Medicine, University Hospital Dubrava, Zagreb, Croatia.\', \'Department for Clinical Microbiology, University Hospital for Infectious Diseases \'Dr. Fran Mihaljević\', Zagreb, Croatia.\', \'School of Dental Medicine, University of Zagreb, Zagreb, Croatia.\', \'Clinical Institute for Transfusion Medicine, Clinical University Hospital Centre Osijek, Osijek, Croatia.\', \'School of Medicine, Catholic University of Croatia, Zagreb, Croatia.\', \'Faculty of Medicine, University of Rijeka, Rijeka, Croatia.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.3389/fimmu.2022.816159
?:hasPublicationType
?:journal
  • Frontiers in immunology
is ?:pmid of
?:pmid
?:pmid
  • 35273599
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.803
?:rankingScore_hIndex
  • 69
?:title
  • Is Better Standardization of Therapeutic Antibody Quality in Emerging Diseases Epidemics Possible?
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all